Evidence map›Paper›PMID 26860769›Full record

ArticleGut2017

Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase.

Nikhil Vergis, Wafa Khamri, Kylie Beale, Fouzia Sadiq, Mina O Aletrari, Celia Moore, Stephen R Atkinson, Christine Bernsmeier, Lucia A Possamai, Gemma Petts and 12 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Gut, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03069300 (The Mechanism of Action of N-acetylcysteine for Reducing the Risk of Infection in Alcoholic Hepatitis), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03069300 phase3unknown statusnot on this map

The Mechanism of Action of N-acetylcysteine for Reducing the Risk of Infection in Alcoholic Hepatitis

TypeinterventionalSponsorImperial College LondonRan2015 to 2025Enrolled42ConditionsAlcoholic Hepatitis, InfectionArmsN-acetyl cysteine (NAC)
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Myeloid cells in chronic liver inflammation.Cellular & molecular immunology · 2025
    Review
  5. Review
  6. Article
  7. Comparison of fungalWorld journal of hepatology · 2024
    Article
  8. Article
  9. Review
  10. Acute-on-chronic liver failure: far to go-a review.Critical care (London, England) · 2023
    Review
  11. Article
  12. Elevated blood monocyte counts in alcohol-associated hepatitis.JGH open : an open access journal of gastroenterology and hepatology · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Gut and liver · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Nikhil VergisDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.ORCID 0000-0002-4157-6757
Wafa KhamriDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Kylie BealeDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Fouzia SadiqDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Mina O AletrariDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Celia MooreDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Stephen R AtkinsonDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Christine BernsmeierDepartment of Hepatology, King's College Hospital, Institute of Liver Studies, London, UK.
Lucia A PossamaiDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Gemma PettsDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Jennifer M RyanDepartment of Hepatology, King's College Hospital, Institute of Liver Studies, London, UK.
Robin D AbelesDepartment of Hepatology, King's College Hospital, Institute of Liver Studies, London, UK.
Sarah JamesDepartment of Hepatology, University College, London, UK.
Matthew FoxtonChelsea and Westminster Hospital, London, UK.
Brian HoganDepartment of Hepatology, Royal Free Hospital, London, UK.
Graham R FosterDepartment of Gastroenterology, Royal London Hospital, London, UK.
Alastair J O'BrienDepartment of Hepatology, University College, London, UK.
Yun MaDepartment of Hepatology, King's College Hospital, Institute of Liver Studies, London, UK.
Debbie L ShawcrossDepartment of Hepatology, King's College Hospital, Institute of Liver Studies, London, UK.
Julia A WendonDepartment of Hepatology, King's College Hospital, Institute of Liver Studies, London, UK.
Charalambos G AntoniadesDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Mark R ThurszDepartment of Hepatology and Gastroenterology, Imperial College, London, UK.
Imperial College London · GBKing's College Hospital · GBUniversity College London · GBChelsea and Westminster Hospital · GBRoyal London Hospital · GBSt Mary's Hospital · GBThe Royal Free Hospital · GB

Funding

Department of Health 08/14/44Medical Research Council MR/J006742/1Medical Research Council MR/K010514/1Medical Research Council MR/M003132/1Wellcome TrustWellcome Trust WT100566MA
6 · The paper itself

Abstract

objectiveIn order to explain the increased susceptibility to serious infection in alcoholic hepatitis, we evaluated monocyte phagocytosis, aberrations of associated signalling pathways and their reversibility, and whether phagocytic defects could predict subsequent infection.

designMonocytes were identified from blood samples of 42 patients with severe alcoholic hepatitis using monoclonal antibody to CD14. Phagocytosis and monocyte oxidative burst (MOB) were measured ex vivo using flow cytometry, luminometry and bacterial killing assays. Defects were related to the subsequent development of infection. Intracellular signalling pathways were investigated using western blotting and PCR. Interferon-γ (IFN-γ) was evaluated for its therapeutic potential in reversing phagocytic defects. Paired longitudinal samples were used to evaluate the effect of in vivo prednisolone therapy.

resultsMOB, production of superoxide and bacterial killing in response to

conclusionsMonocyte oxidative burst and bacterial killing is impaired in alcoholic hepatitis while bacterial uptake by phagocytosis is preserved. Defective MOB is associated with reduced expression of NADPH oxidase in these patients and predicts the development of infection and death.

Indexed as

PhagocytosisRespiratory BurstAdultAnti-Inflammatory AgentsBacterial InfectionsCase-Control StudiesCells, CulturedCoculture TechniquesColony Count, MicrobialEscherichia coliFemaleHepatitis, AlcoholicHumansInterferon-gammaMaleMembrane GlycoproteinsAnti-Inflammatory AgentsCYBB protein, humanInterferon-gammaMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesPrednisoloneSOCS1 protein, humanSuppressor of Cytokine Signaling 1 ProteinALCOHOLIC LIVER DISEASEBACTERIAL INFECTIONIMMUNOLOGY IN HEPATOLOGY

Identifiers

PMID26860769
PMCPMC5534772
OpenAlexW2265519772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.